MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

25 Oct 2024 Evaluate
The sales is pegged at Rs. 347.16 millions for the September 2024 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 395.44 millions during the year-ago period.The Net Profit of the company registered a slight decline of -15.75% to Rs. 105.67  millions from Rs. 125.43 millions.Operating Profit reported a sharp decline to 157.10 millions from 178.21 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 347.16 395.44 -12.21 735.43 891.32 -17.49 1698.22 1483.85 14.45
Other Income 3.19 10.97 -70.92 8.43 21.72 -61.19 43.66 65.88 -33.73
PBIDT 157.10 178.21 -11.85 347.85 424.02 -17.96 831.00 802.17 3.59
Interest 0.82 0.51 60.78 1.48 0.76 94.74 2.29 1.76 30.11
PBDT 156.28 177.70 -12.05 346.37 423.26 -18.17 828.71 800.41 3.54
Depreciation 14.36 8.84 62.44 25.84 16.33 58.24 35.36 25.76 37.27
PBT 141.92 168.86 -15.95 320.53 406.93 -21.23 793.35 774.65 2.41
TAX 36.25 43.43 -16.53 82.49 104.29 -20.90 201.71 194.96 3.46
Deferred Tax 0.08 1.11 -92.79 0.61 2.07 -70.53 3.75 2.55 47.06
PAT 105.67 125.43 -15.75 238.04 302.64 -21.35 591.64 579.69 2.06
Equity 108.97 72.64 50.01 108.97 72.64 50.01 72.64 72.64 0.00
PBIDTM(%) 45.25 45.07 0.41 47.30 47.57 -0.57 48.93 54.06 -9.48
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..